164 related articles for article (PubMed ID: 32427034)
1. Plasma Neprilysin Displays No Relevant Association With Neurohumoral Activation in Chronic HFrEF.
Prausmüller S; Arfsten H; Spinka G; Freitag C; Bartko PE; Goliasch G; Strunk G; Pavo N; Hülsmann M
J Am Heart Assoc; 2020 Jun; 9(11):e015071. PubMed ID: 32427034
[TBL] [Abstract][Full Text] [Related]
2. Relation of neurohumoral activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators.
Benedict CR; Johnstone DE; Weiner DH; Bourassa MG; Bittner V; Kay R; Kirlin P; Greenberg B; Kohn RM; Nicklas JM
J Am Coll Cardiol; 1994 May; 23(6):1410-20. PubMed ID: 7909822
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction.
Bishu K; Deswal A; Chen HH; LeWinter MM; Lewis GD; Semigran MJ; Borlaug BA; McNulty S; Hernandez AF; Braunwald E; Redfield MM
Am Heart J; 2012 Nov; 164(5):763-770.e3. PubMed ID: 23137508
[TBL] [Abstract][Full Text] [Related]
4. Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure.
Vodovar N; Séronde MF; Laribi S; Gayat E; Lassus J; Januzzi JL; Boukef R; Nouira S; Manivet P; Samuel JL; Logeart D; Cohen-Solal A; Richards AM; Launay JM; Mebazaa A;
JACC Heart Fail; 2015 Aug; 3(8):629-36. PubMed ID: 26251090
[TBL] [Abstract][Full Text] [Related]
5. Altered serum levels of neprilysin in heart failure patients with reduced ejection fraction.
Nemcekova V; Malikova E; Goncalvesova E; Krenek P; Klimas J
Bratisl Lek Listy; 2021; 122(1):28-33. PubMed ID: 33393317
[TBL] [Abstract][Full Text] [Related]
6. Soluble neprilysin does not correlate with outcome in heart failure with preserved ejection fraction.
Goliasch G; Pavo N; Zotter-Tufaro C; Kammerlander A; Duca F; Mascherbauer J; Bonderman D
Eur J Heart Fail; 2016 Jan; 18(1):89-93. PubMed ID: 26725876
[TBL] [Abstract][Full Text] [Related]
7. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
8. Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction.
Moliner P; Lupón J; Barallat J; de Antonio M; Domingo M; Núñez J; Zamora E; Galán A; Santesmases J; Pastor C; Bayes-Genis A
Int J Cardiol; 2018 Apr; 257():188-192. PubMed ID: 29415801
[TBL] [Abstract][Full Text] [Related]
9. Excess renin is attributed to the combination of forward and backward failure in HFrEF.
Arfsten H; Heitzinger G; Prausmüller S; Weidenhammer A; Goliasch G; Bartko PE; Spinka G; Hülsmann M; Pavo N
ESC Heart Fail; 2024 Jun; 11(3):1748-1757. PubMed ID: 38459668
[TBL] [Abstract][Full Text] [Related]
10. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH
Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866
[TBL] [Abstract][Full Text] [Related]
11. Galectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure.
Stoltze Gaborit F; Bosselmann H; Kistorp C; Iversen K; Kumler T; Gustafsson F; Goetze JP; Sölétormos G; Tønder N; Schou M
BMC Cardiovasc Disord; 2016 May; 16():117. PubMed ID: 27246703
[TBL] [Abstract][Full Text] [Related]
12. Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP.
Bayes-Genis A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Gastelurrutia P; Vila J; Peñafiel J; Gálvez-Montón C; Lupón J
Rev Esp Cardiol (Engl Ed); 2015 Dec; 68(12):1075-84. PubMed ID: 26297179
[TBL] [Abstract][Full Text] [Related]
13. Impact of Body Mass Index on the Accuracy of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide for Predicting Outcomes in Patients With Chronic Heart Failure and Reduced Ejection Fraction: Insights From the PARADIGM-HF Study (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial).
Nadruz W; Claggett BL; McMurray JJ; Packer M; Zile MR; Rouleau JL; Desai AS; Swedberg K; Lefkowitz M; Shi VC; Prescott MF; Solomon SD
Circulation; 2016 Nov; 134(22):1785-1787. PubMed ID: 27895026
[No Abstract] [Full Text] [Related]
14. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.
Salah K; Stienen S; Pinto YM; Eurlings LW; Metra M; Bayes-Genis A; Verdiani V; Tijssen JGP; Kok WE
Heart; 2019 Aug; 105(15):1182-1189. PubMed ID: 30962192
[TBL] [Abstract][Full Text] [Related]
15. Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction.
Savarese G; Orsini N; Hage C; Dahlström U; Vedin O; Rosano GMC; Lund LH
J Card Fail; 2018 Jun; 24(6):365-374. PubMed ID: 29597053
[TBL] [Abstract][Full Text] [Related]
16. Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients.
Bayés-Genís A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Urrutia A; Lupón J
J Am Coll Cardiol; 2015 Feb; 65(7):657-65. PubMed ID: 25677426
[TBL] [Abstract][Full Text] [Related]
17. Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure.
Passino C; Severino S; Poletti R; Piepoli MF; Mammini C; Clerico A; Gabutti A; Nassi G; Emdin M
J Am Coll Cardiol; 2006 May; 47(9):1835-9. PubMed ID: 16682309
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.
Zile MR; Claggett BL; Prescott MF; McMurray JJ; Packer M; Rouleau JL; Swedberg K; Desai AS; Gong J; Shi VC; Solomon SD
J Am Coll Cardiol; 2016 Dec; 68(22):2425-2436. PubMed ID: 27908347
[TBL] [Abstract][Full Text] [Related]
19. Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction.
Tromp J; Khan MA; Klip IT; Meyer S; de Boer RA; Jaarsma T; Hillege H; van Veldhuisen DJ; van der Meer P; Voors AA
J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28360225
[TBL] [Abstract][Full Text] [Related]
20. Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions.
Pan W; Yang D; Yu P; Yu H
BMC Cardiovasc Disord; 2020 Apr; 20(1):208. PubMed ID: 32354356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
